On November 13, Rocket Lab USA, Inc. fell 4.1% in Regular Trading, trading at $61.3201 per share, with Turnover of $104 million.
The move came as the market continued to digest modest analyst target-price cuts, weaker-than-expected third-quarter profitability, and the proposed roughly $8 billion acquisition of Iridium Communications.
Recent disclosures showed Morgan Stanley lowered its price target to $103 from $105 and Needham cut its target to $100, while both remained constructive. Rocket Lab USA, Inc. reported third-quarter revenue of $267.8 million, up 73% year over year and above expectations, but posted a per-share loss of $0.12, worse than expected. Options positioning also pointed to capped-upside sentiment, including a roughly $1.05 million far-out-of-the-money January 2027 $80 call sale. At the same time, Berenberg raised its target to $85 from $83 and maintained a Buy rating, indicating that analyst views remain positive longer term even as near-term pressure persists.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments